Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market.
They look at most sectors, with a particular focus on digital B2B companies – enterprise software and
technology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive.
They also invest in companies commercialising IP from University College London via the UCL Technology Fund.
Industries: Health Care
mHealth
Pharmaceutical
Communications Infrastructure
Wired Telecommunications
B2B
Collaboration
Mobile Apps
Software
Commercial Insurance
Insurance
Marketing Automation
SaaS
Sales
Sales Automation
Lifestyle
Nightclubs
Restaurants
Finance
Financial Services
Venture Capital
Energy
Energy Management
Renewable Energy
Biotechnology
Clinical Trials
Medical
Life Science
Manufacturing
Medical Device
Location: London, England, United Kingdom
